Skip Navigation

European Journal of Heart Failure 2000 2(1):7-11; doi:10.1016/S1388-9842(99)00061-6
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Opasich, C.
Right arrow Articles by Tavazzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Opasich, C.
Right arrow Articles by Tavazzi, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2000 European Society of Cardiology

Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?

Cristina Opasicha,*, Alessandra Russob, Renato Mingronea, Mara Zambellia and Luigi Tavazzib

a S. Maugeri Foundation, Institute of Care and Scientific Research, Cardiology Division, Medical Center of Pavia 27100 Pavia, Italy
b Cardiology Division, Policlinico S. Matteo Institute of Care and Research 27100 Pavia, Italy

* Corresponding author. Tel.: +39-382-592-1; fax: +39-382-592-099. E-mail address: copasich{at}fsm.it


  Abstract

Part of the management of refractory heart failure is treatment aimed at preventing organ damage due to inadequate oxygen delivery, improving hemodynamics, and maximizing cardiac output while maintaining only mildly elevated ventricular filling pressures The aim of this paper is to review the most updated indications on intravenous inotropic agents, and to compare their cardiac and peripheral effects. Finally, clinical implications of their use (alone or in combination) are reviewed.

Key Words: Intravenous inotropics • Intensive therapy • Heart failure

Received February 12, 1999; Revised October 19, 1999; Accepted October 21, 1999


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.